The identification of an NMO-specific autoantibody (NMO IgG) and aquaporin 4 (AQP4) as an antigenic target of this antibody defined NMO as a distinct disease with unique pathogenic and pathological characteristics [3]. Here, AQP4 is linked to neuromyelitis optica.